18
Participants
Start Date
October 31, 2012
Primary Completion Date
March 8, 2017
Study Completion Date
October 1, 2020
Induction Chemotherapy followed by Response Adapted Chemoradiation
All patients receive induction chemotherapy with 2 cycles of paclitaxel and carboplatin followed by response adapted, de-escalated chemoradiation. Patients with a complete or partial response will receive 54 Gy with concurrent paclitaxel and patients with stable disease will receive 60 Gy with concurrent paclitaxel.
University of California Comprehensive Cancer Center, Sacramento
University of California, Davis
OTHER